Study #2019-0502
Cryoablation Challenge Evaluated in Adaptive-Immune Resistance (CEDAR)
MD Anderson Study Status
Not Accepting
Treatment Agent
Immunotherapeutic Agent
Description
This interventional trial studies the effectiveness of adding cryoablation treatment in patients who are receiving standard of care immunotherapy to treat cancer that is has spread to other parts of the body (metastatic). Cryoablation uses a probe that freezes the tissue around the tumor to try to kill the cancer cells. Using cryoablation to treat cancerous lesions may help to kill the cancer cells.
Resources and Links
Phone Number: 1-877-MDA-6789
Information and next steps
Disease:
Metastatic Malignant Neoplasm
Study phase:
Not applicable
Physician name:
Alda Tam
Department:
Interventional Radiology
For general questions about clinical trials:
1-855-807-9574
Help #EndCancer
Give Now
Donate Blood
Our patients depend on blood and platelet donations.
Shop MD Anderson
Show your support for our mission through branded merchandise.